focus -WSS

focus

author：fashion 2025-09-06 02:06:40 - browse：262

Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： There’s a way to spot data fakery. All journals should be using it

WSS

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

There’s a way to spot data fakery. All journals should be using it

The stock market has soared this year, but will it last? Experts weigh in

What causes rare myocarditis in young men after Covid vaccines?

Hormonal contraceptives don’t actually treat endometriosis

Dementia risk linked to living in disadvantaged areas: Study

hotspot

focus

hotspot

Drug repurposing or repositioning? The language matters

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

23andMe had bad news about my health. I wish a person had delivered it

Extensive review finds private equity owners jack up cost of care

Malaria cases in Florida and Texas: Here’s what you need to know

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Sports medicine is finally prioritizing gender equality

Caribou posts encouraging results on off

Sports medicine is finally prioritizing gender equality

'CMA Fest' 2023: How to watch, who is performing and more

hotspot

Dementia risk linked to living in disadvantaged areas: Study

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Biden warns of ‘dark winter’ during final presidental debate

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Scientists grapple with ethics of stem cell research

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

focus

hotspot

explore

focus